Centre for Liver Research and NIHR Biomedical Research Unit, Institute for Biomedical Research, The Medical School, University of Birmingham, Birmingham, B15 2TT, UK.
Am J Physiol Gastrointest Liver Physiol. 2013 Mar 1;304(5):G469-78. doi: 10.1152/ajpgi.00407.2012. Epub 2012 Dec 20.
Platelets have recently been shown to drive liver injury in murine models of viral hepatitis and promote liver regeneration through the release of serotonin. Despite their emerging role in inflammatory liver disease, little is known about the mechanisms by which platelets bind to the hepatic vasculature. Therefore, we referenced public expression data to determine the profile of potential adhesive receptors expressed by hepatic endothelium. We then used a combination of tissue-binding and flow-based endothelial-binding adhesion assays to show that resting platelets bind to human hepatic sinusoidal endothelial cells and that the magnitude of adhesion is greatly enhanced by thrombin-induced platelet activation. Adhesion was mediated by the integrins Gp1b, αIIbβIII, and αvβ3, as well as immobilized fibrinogen. Platelet binding to hepatic endothelial cells resulted in NF-κB activation and increased chemokine secretion. The functional relevance of platelet binding was confirmed by experiments that showed markedly increased binding of neutrophils and lymphocytes to hepatic endothelial cells under shear conditions replicating those found in the hepatic sinusoid, which was in part dependent on P-selectin expression. Thus the ability of platelets to activate endothelium and promote leukocyte adhesion may reflect an additional mechanism through which they promote liver injury.
血小板最近被证明在病毒性肝炎的鼠模型中驱动肝损伤,并通过释放 5-羟色胺促进肝再生。尽管它们在炎症性肝病中的作用正在显现,但对于血小板与肝血管结合的机制知之甚少。因此,我们参考了公共表达数据来确定肝内皮细胞表达的潜在粘附受体的特征。然后,我们使用组织结合和基于流动的内皮结合粘附测定的组合,表明静止的血小板结合到人类肝窦内皮细胞,并且粘附的幅度通过凝血酶诱导的血小板活化大大增强。粘附由整合素 Gp1b、αIIbβIII 和 αvβ3 以及固定化纤维蛋白原介导。血小板与肝内皮细胞的结合导致 NF-κB 激活和趋化因子分泌增加。血小板与肝内皮细胞结合的功能相关性通过实验得到证实,在模拟肝窦中发现的剪切条件下,中性粒细胞和淋巴细胞与肝内皮细胞的结合明显增加,这部分依赖于 P 选择素的表达。因此,血小板激活内皮和促进白细胞黏附的能力可能反映了它们促进肝损伤的另一种机制。